Chronic Kidney Disease
The Pharmacy Times® Chronic Kidney Disease resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.
What can we help you find?
No Significant Difference with Vitamin D3, Omega-3 Fatty Acids in Patients with Chronic Kidney Disease
Neither vitamin D nor omega-3 fatty acid supplementation were found to significantly inhibit changes in serum creatinine and cystatin C decline over 5 years among adults with type 2 diabetes.
Phase 3 Trial Shows Positive Efficacy, No Increased Cardiovascular Risk for Hemoglobin-Increasing Drug
Roxadustat for the treatment of patients with anemia from chronic kidney disease was shown to have positive efficacy and no increased cardiovascular risk in patients dependent and not dependent on dialysis.
The oral therapy is indicated to act as both a monotherapy and a combination therapy to improve glycemic control. It is also indicated to prevent cardiovascular and renal death in patients with CKD.
According to the National Institute of Diabetes and Digestive and Kidney Diseases, more than 661,000 Americans have kidney failure.
According to the CDC, approximately 1 of 3 patients with type 1 and 2 diabetes mellitus (DM) has CKD. What do we need to know about patients with DM and CKD?
High consumption of sugary beverages has previously been linked to obesity, diabetes, and some types of cancer.
A multimethod approach including use of refill data may be the most effective method to identify nonadherence in young patients with chronic kidney disease.
In an additional analysis from the CANVAS program, new data reinforce evidence of improved renal outcomes for those with type 2 diabetes and chronic kidney disease.
Screening for HBV among high-risk populations is crucial to stopping transmission of the virus.
HIV-positive patients need to maintain healthy body weight, quit smoking, eat well, exercise regularly and treat hypertension, diabetes and dyslipidemia.
Direct-acting antivirals drugs show similar cure rates in co-infected patients as high as mono-infected patients.
Heplisav-B is the only 2-dose hepatitis B vaccine recombinant approved in the United States.
+ Load More